Recent Study: Samaritan Pharmaceuticals, Inc. - Product Pipeline Review - 2012

New Pharmaceuticals market report from Global Markets Direct: "Samaritan Pharmaceuticals, Inc. - Product Pipeline Review - 2012"
By: Fast Market Research, Inc.
 
 
Spread the Word
Listed Under

Tags:
Samaritan
Pharmaceuticals
Pharma

Industry:
Medical

Location:
Massachusetts - US

Oct. 8, 2012 - PRLog -- Global Market Direct's pharmaceuticals report, "Samaritan Pharmaceuticals, Inc. - Product Pipeline Review - 2012" provides data on the Samaritan Pharmaceuticals, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Samaritan Pharmaceuticals, Inc.'s corporate website, SEC filings, investor presentations and featured press releases, both from Samaritan Pharmaceuticals, Inc. and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

* Samaritan Pharmaceuticals, Inc. - Brief Samaritan Pharmaceuticals, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
* Review of current pipeline of Samaritan Pharmaceuticals, Inc. human therapeutic division.
* Overview of pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of Samaritan Pharmaceuticals, Inc. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the Samaritan Pharmaceuticals, Inc.'s pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.

------------------------------------------------------------
Full Report Details at
- http://www.fastmr.com/prod/468600_samaritan_pharmaceutica...
------------------------------------------------------------

Reasons to buy

* Evaluate Samaritan Pharmaceuticals, Inc.'s strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of Samaritan Pharmaceuticals, Inc. in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the Samaritan Pharmaceuticals, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with Samaritan Pharmaceuticals, Inc..
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of Samaritan Pharmaceuticals, Inc. and identify potential opportunities in those areas.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Samaritan Pharmaceuticals, Inc. Snapshot
Samaritan Pharmaceuticals, Inc. Overview
Key Information
Key Facts
Samaritan Pharmaceuticals, Inc. - Research and Development Overview
Key Therapeutic Areas
Samaritan Pharmaceuticals, Inc. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Samaritan Pharmaceuticals, Inc. - Pipeline Products Glance
Samaritan Pharmaceuticals, Inc. - Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Samaritan Pharmaceuticals, Inc. - Drug Profiles
SP-03
Product Description
Mechanism of Action
R&D Progress
SP-04
Product Description
Mechanism of Action
R&D Progress
SP-08
Product Description
Mechanism of Action
R&D Progress
SP-10
Product Description
Mechanism of Action
R&D Progress
SP-1000
Product Description
Mechanism of Action
R&D Progress
SP-233
Product Description
Mechanism of Action
R&D Progress
SP-30
Product Description
Mechanism of Action
R&D Progress
SP-sc4
Product Description
Mechanism of Action
R&D Progress
SP-sc7
Product Description
Mechanism of Action
R&D Progress
uteroglobin
Product Description
Mechanism of Action
R&D Progress
Samaritan Pharmaceuticals, Inc. - Pipeline Products by Route of Administration
Samaritan Pharmaceuticals, Inc. - Pipeline Products By Mechanism of Action
Samaritan Pharmaceuticals, Inc. - Dormant Projects
Samaritan Pharmaceuticals, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Samaritan Pharmaceuticals, Inc. - Key Manufacturing Facilities
Financial Deals Landscape
Samaritan Pharmaceuticals, Inc., Deals Summary
Samaritan Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deal Details
Asset Transactions
Samaritan Pharma Reacquires Canadian Rights To Anticort
Partnerships
EUSA Pharma Signs Distribution Agreement With Samaritan Pharma
Samaritan Pharma Signs An Agreement With Shire Human Genetic
Samaritan Pharma Enters Into Collaboration With Pharmaplaz
Samaritan Pharma Enters Into Marketing Agreement With Shire
Licensing Agreements
Samaritan Pharma Enters Into Licensing Agreement With Georgetown University For Benzamide
Samaritan Pharma Enters Into Licensing Agreement With Abiogen Pharma
Samaritan Pharma Enters Into Licensing Agreement With EUSA Pharma
Samaritan Pharma Enters Into Licensing Agreement With Georgetown University For PBR
Samaritan Pharma Enters Into Licensing Agreement With Georgetown University For SBDDSI
Samaritan Pharma Enters Into Licensing Agreement With Georgetown University For SP-6300
Samaritan Enters Into Licensing Agreement With George Town University
Samaritan Therapeutics Enters Into Research Agreement With The Research Institute of McGill University
Samaritan Pharma Enters Into Licensing Agreement Georgetown University
Samaritan Pharma Enters Into Licensing Agreement With ONY
Samaritan Pharma Enters Into Licensing Agreement With Molteni
Equity Offering
Samaritan Pharma Completes Private Placement Of $0.8 Million
Acquisition

Full Table of Contents is available at:
-- http://www.fastmr.com/catalog/product.aspx?productid=4686...

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information.
End
Email:***@fastmr.com Email Verified
Phone:1.800.844.8156
Zip:01267
Tags:Samaritan, Pharmaceuticals, Pharma
Industry:Medical
Location:Massachusetts - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Fast Market Research PRs
Trending News
Most Viewed
Top Daily News



Like PRLog?
9K2K1K
Click to Share